Search - tctmd.com

Displaying 1 - 20 of 165

Sort: Relevancy | Date

Presentation THT 2022

Implications of RVF in Structural Heart Procedures

Presenter: Rebecca Hahn

February 02, 2022

Presentation THT 2022

Executing Clinical Follow Up In the Modern Era

Presenter: Jodi Akin

February 02, 2022

Presentation THT 2022

Clinical Trials During COVID-19: Innvestigator Perspective

Presenter: Scott Solomon

February 02, 2022

Presentation THT 2022

Novel Medical Therapies for AS

Presenter: Brian Lindman

February 02, 2022

Presentation THT 2022

Moderate AS and HD - TAVR Unload and Beyond

Presenter: Nicolas Van Mieghem

February 02, 2022

Presentation THT 2022

Research Consortium / Collabratories

Presenter: Mona Fiuzat

February 02, 2022

Presentation THT 2022

Challenges With Cardiogenic Shock Studies in the US

Presenter: Chuck Simonton

February 02, 2022

Presentation THT 2022

Tricuspid Devices and Studies

Presenter: Susheel Kodali

February 02, 2022

Presentation THT 2022

Innovation in Heart Failure Trial Designs

Presenter: Ori Ben-Yehuda

February 02, 2022

Presentation THT 2022

Percutanous Mitral Valve Repair Devices (Mitral TEER vs Annuloplasty/Chordal Suspension)

Presenter: Mark Reisman

February 02, 2022

Presentation THT 2022

Heart Failure Trials in the Modern Era: Where Are We Going?

Presenter: Andrew Farb

February 02, 2022

Presentation THT 2022

Mitraclip Patient Selection

Presenter: Scott Lim

February 02, 2022

Presentation THT 2022

Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial

Presenter: Akshay Desai

February 02, 2022

Presentation THT 2022

Hemodynamic Profiles Across the Range of Left Ventricular Ejection Fraction in Heart Failure With Preserved Ejection Fraction – Potential Therapeutic Implications

Presenter: Sebastian Rosch

February 02, 2022

Presentation THT 2022

Ancora

Presenter: Ulrich Jorde

February 02, 2022

Presentation THT 2022

SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients

Presenter: Shashank Sinha

February 02, 2022

Presentation THT 2022

BioVentrix

Presenter: Jerry Estep

February 02, 2022

Presentation THT 2022

Interatrial Shunting in Chronic Heart Failure: Results From the RELIEVE-HF Roll-In Cohort

Presenter: JoAnn Lindenfeld

February 02, 2022

Presentation THT 2022

Structural Remodeling Using Transcatheter Therapies: Contrast to Medical Therapies

Presenter: Daniel Burkhoff

February 02, 2022

Presentation THT 2022

Utilization of Left-Atrial Venous Arterial Extracorporeal Membrane Oxygenation for Biventricular Failure in Cardiogenic Shock

Presenter: Waleed Al-Darzi

February 02, 2022

Advertisement

Implications of RVF in Structural Heart Procedures

Executing Clinical Follow Up In the Modern Era

Clinical Trials During COVID-19: Innvestigator Perspective

Novel Medical Therapies for AS

Moderate AS and HD - TAVR Unload and Beyond

Research Consortium / Collabratories

Challenges With Cardiogenic Shock Studies in the US

Tricuspid Devices and Studies

Innovation in Heart Failure Trial Designs

Percutanous Mitral Valve Repair Devices (Mitral TEER vs Annuloplasty/Chordal Suspension)

Heart Failure Trials in the Modern Era: Where Are We Going?

Mitraclip Patient Selection

Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial

Hemodynamic Profiles Across the Range of Left Ventricular Ejection Fraction in Heart Failure With Preserved Ejection Fraction – Potential Therapeutic Implications

Ancora

SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients

BioVentrix

Interatrial Shunting in Chronic Heart Failure: Results From the RELIEVE-HF Roll-In Cohort

Structural Remodeling Using Transcatheter Therapies: Contrast to Medical Therapies

Utilization of Left-Atrial Venous Arterial Extracorporeal Membrane Oxygenation for Biventricular Failure in Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content